The Effects of Orange Juice on Plasma Lipids

March 23, 2018 updated by: Elizabeth Simpson, University of Nottingham

An Investigation Into the Effects of Orange Juice on Plasma Lipids - an Extension to J/06/2010

The aim of this study is primarily to investigate the ability of antioxidants found in orange juice (OJ) to improve the serum lipid profile. Overweight or mildly obese men, who are otherwise healthy, but with elevated serum total cholesterol concentration will be recruited. The time commitment for subjects is ~14wks. Subjects will attend the laboratory on 5 occasions after fasting from midnight. The 1st is a medical screening. Laboratory visits 2 & 5 will take ~90min and will be separated by 3 months, during which time subjects will consume 250ml of an orange drink (either OJ or an orange flavoured control drink) once a day. During visits 2 & 5, subjects will have a scan to assess their %body fat using a low-dose x-ray machine, a 20ml blood sample taken and a small sample of fat tissue (about the size of a haricot bean)taken from underneath the skin of the belly. Subjects will record their food intake for 3-days in weeks 3, 7 and 11 of consuming the drink, and come to the lab for visits 3&4 during weeks 4&8. Laboratory visits 3&4 repeat measurements taken in the 1st (screening) visit.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background:

Overweight and mild obesity are associated with insulin resistance and mild elevations in lipid risk factors which are not usually sufficiently abnormal to merit treatment. Such people are encouraged to lose weight to reduce their risk of progressing to type 2 diabetes and coronary heart disease, but there is clearly a potential role for dietary modifications to maximize any potential benefit of this weight loss. Flavonoids are known to have vascular effects which might enhance substrate delivery to metabolically active tissues, and thus improve insulin sensitivity. Moreover, there is much interest in the potentially beneficial effect of flavonoids on serum lipid profile.

There are many different dietary sources of flavonoids, with fruits such as apples, berries and citrus being rich sources. However, some researchers have expressed concern that a high dietary intake of 100% juice may contribute to the development of insulin resistance, obesity and the Metabolic Syndrome (Bazzano, Li et al. 2008), although this is not universally accepted (Fujioka, Greenway et al. 2006; O'Neil and Nicklas 2008). To date, there have been no studies investigating the effects of citrus fruits on indices of cardio-metabolic health in people who are presently healthy but are at risk of developing some features of the Metabolic Syndrome.

Aims:

To investigate the effects of orange juice (OJ) intake on appetite hormones, blood pressure and plasma lipids. In addition we aim to investigate any gene expression changes associated with OJ consumption, in particular in adipose tissue.

Experimental protocol and methods:

Overweight or obese men (BMI 27-35), who are otherwise healthy, will be recruited onto the study. They will attend the 'David Greenfield Human Physiology' laboratories on 5 convenient mornings, following an overnight fast. The 1st visit is a medical screening and will involve signing a consent form, completing medical screening, food frequency and activity questionnaires, having height, weight, and hip/waist circumference measurements taken and a sample of blood taken for CBC, urea, electrolytes, LFT, TFT, glucose and insulin analysis. Subjects will then be asked to complete a 3-day diet diary for macronutrient assessment. The 2nd visit will involve having a DEXA body composition scan, an adipose tissue biopsy and a blood sample taken for white blood cell harvest, serum lipids, glucose, insulin, cytokines, appetite hormones and catecholamine analysis. Starting on the following morning, subjects will then consume an orange drink (either OJ or a carbohydrate matched orange flavoured drink) once a day for 12 wks. A 3-day diet diary for macronutrient assessment will be recorded during wks 3,7and 11 of taking the drink, and measurements made at screening will be repeated on visits 3 and 4 which will take place in weeks 4 and 8. The final laboratory (5th) visit will be identical to visit 2.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Notts
      • Nottingham, Notts, United Kingdom, NG72UH
        • David Greenfield Human Physiology Unit, University of Nottingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • BMI 27-35
  • waist circumference >96cm.
  • Serum Total Cholesterol >5mmol/l

Exclusion Criteria:

  • Any clinically significant metabolic or endocrine abnormalities
  • screening blood results (other than lipids) outside of the normal range
  • fasting total cholesterol >7.0mmol/l
  • taking routine medication
  • herbal supplement use
  • food allergies or sensitivities related to the investigational product Regular citrus consumers (whole fruit or juice) daily consumption of sucrose or high fructose corn syrup containing soft-drinks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Orange Juice
Juice high in flavonoids
250ml of orange juice or a sugars matched orange drink daily
Placebo Comparator: Orange Drink
Sugars matched, low flavonoids orange drink
250ml of orange juice or a sugars matched orange drink daily

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Serum Cholesterol concentration
Time Frame: after 3 months' intervention
Fasting Serum total cholesterol concentration (mmol/l)
after 3 months' intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
High Density Cholesterol (HDL)
Time Frame: after 3 months' intervention
Fasting Serum HDL concentration
after 3 months' intervention
Low density cholesterol
Time Frame: after 3 months' intervention
Fasting Serum LDL concentration
after 3 months' intervention
Gene expression in adipose tissue
Time Frame: after 3 months' intervention
Expression of genes related to lipid metabolism in adipose tissue
after 3 months' intervention
leptin
Time Frame: after 3 month intervention
fasting Serum Leptin concentration
after 3 month intervention
IL-1
Time Frame: afetr 3 month intervention
Serum IL-1 concentration
afetr 3 month intervention
Blood Pressure
Time Frame: after 3months intervention
Resting blood pressure, measured semi-supine
after 3months intervention
Ghrelin
Time Frame: After 3 months intervention
Fasting Plasma Ghrelin concentration
After 3 months intervention
GLP-1
Time Frame: After 3 months intervention
Fasting Plasma GLP-1 concentration
After 3 months intervention
insulin
Time Frame: After 3 months intervention
Fasting serum Insulin concentration
After 3 months intervention
IL-6
Time Frame: After 3 months intervention
Serum IL-6 concentration
After 3 months intervention
TNF alpha
Time Frame: After 3 months intervention
Serum TNF-Alpha concentration
After 3 months intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ian A Macdonald, PhD, Nottingham University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

May 9, 2011

First Submitted That Met QC Criteria

May 9, 2011

First Posted (Estimate)

May 10, 2011

Study Record Updates

Last Update Posted (Actual)

March 27, 2018

Last Update Submitted That Met QC Criteria

March 23, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Orange Juice

3
Subscribe